Did Zuckerberg Just Have His iPhone Moment?
Last week Mark Zuckerberg unveiled Meta Platforms (NASDAQ: META) latest hardware product, Orion augmented reality glasses,
As it ventures deeper into the world of AR and wearable technology, there’s a very real possibility that this is Meta’s “iPhone moment,” revolutionizing the tech landscape as Apple’s iconic smartphone did in 2007.
» Read more about: Did Zuckerberg Just Have His iPhone Moment? »
Read More
14.7 Billion Reasons To Buy Meta
Meta Platforms (META) has repurchased shares totaling around $14.7 billion so far in 2022. The social media titan, best known for Facebook, bought $5.08 billion of its stock this past quarter — but what does it all mean? Is now the time to buy, or has META become a value trap?
» Read more about: 14.7 Billion Reasons To Buy Meta »
Read More
“SELL”: Wall Street’s Most Accurate Analyst
When Bank of America’s Chief Investment Strategist turned bullish last month amid a plethora of dire sentiment readings, few paid close attention.
Then the markets rose by 20% off their lows.
So, what is Wall Street’s most accurate analyst saying now?
In a word: SELL.
The Bear Market Is Not Over
According to Hartnett,
» Read more about: “SELL”: Wall Street’s Most Accurate Analyst »
Read More
1 Monster Software Stock Even Buffett Owns
When you think of 91 year old Warren Buffett’s stock picks, old stodgy companies with wide moats that spit off massive amounts of cash come to mind. From railways to insurance, the laundry list of market-beating companies Buffett owns through his holding company Berkshire Hathaway is the stuff of legend.
But one sector Buffett has famously avoided up until the last few years is technology,
» Read more about: 1 Monster Software Stock Even Buffett Owns »
Read More
How To Make 100% In Next 11 Months
The most important Federal Reserve announcement ever led to about as much excitement yesterday as two turtles racing to a finishing line.
Prior to the announcement by Chairman Jerome Powell, the market had forecast, with 68% probability, a 50bps rate cut.
That alone signaled that the market had priced in precisely what the Fed delivered and so when expectations became reality not a whole lot happened.
» Read more about: How To Make 100% In Next 11 Months »
Read MoreThe Ivy
1 Cash Cow with Massive Upside
CVS Health (NYSE:CVS) share price declined by over 23% over the past twelve months. Hurting shareholders was the recent leadership transition from CEO Karen Lynch to David Joyner, a shift that brought uncertainty to the company’s direction as investors questioned the company’s stability while facing ongoing challenges.
» Read more about: 1 Cash Cow with Massive Upside »
Read MoreThe Spotlight
Spotlight: Time To Buy Vaccine Manufacturer Before Winter?
It’s impossible to discuss Moderna without mentioning its COVID-19 vaccine, which propelled the stock to record highs in 2021 approaching $500 per share. However, slower sales caused the stock to plunge by almost 80%.
Second-quarter reports in 2023 show a net loss of $1.38 billion, a stark contrast to the net income of $5.4 billion in Q4 2021.
» Read more about: Spotlight: Time To Buy Vaccine Manufacturer Before Winter? »
Read MoreThe Daily
Wall Street: Nuburu, Trilogy Metals, USA Rare Earth surge up to 179 per cent; here’s why
By Vested Finance
Despite a sea of red in the broader US markets, several individual stocks delivered stellar returns this past week, driven by strategic investments, acquisitions, and major partnership deals. While the major indices stumbled, with the S&P 500 and Nasdaq 100 dropping 2.43 per cent and 2.27 per cent respectively,